The stock of Chemours Company (NYSE: CC) has increased by 9.19% when compared to last closing price of $19.25.Despite this, the company has seen a gain of 17.17% in its stock price over the last five trading days. defenseworld.net reported 2026-02-07 that Air Liquide (OTCMKTS:AIQUY – Get Free Report) and Chemours (NYSE: CC – Get Free Report) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk. Dividends Air Liquide pays an annual dividend of
Is It Worth Investing in Chemours Company (NYSE: CC) Right Now?
Additionally, the 36-month beta value for CC is 1.61. There are mixed opinions on the stock, with 4 analysts rating it as a “buy”, 1 rating it as “overweight”, 4 rating it as “hold”, and 0 rating it as “sell”.
The public float for CC is 148.79M and currently, short sellers hold a 10.17% ratio of that float. The average trading volume of CC on February 12, 2026 was 2.69M shares.
CC’s Market Performance
CC stock saw an increase of 17.17% in the past week, with a monthly gain of 42.80% and a quarterly increase of 64.86%. The volatility ratio for the week is 7.66%, and the volatility levels for the last 30 days are 6.15% for Chemours Company (CC). The simple moving average for the past 20 days is 27.17% for CC’s stock, with a 56.81% simple moving average for the past 200 days.
Analysts’ Opinion of CC
Many brokerage firms have already submitted their reports for CC stocks, with Mizuho repeating the rating for CC by listing it as a “Outperform”. The predicted price for CC in the upcoming period, according to Mizuho is $19 based on the research report published on March 27, 2025 of the previous year 2025.
Truist, on the other hand, stated in their research note that they expect to see CC reach a price target of $27. The rating they have provided for CC stocks is “Buy” according to the report published on January 28th, 2025.
Mizuho gave a rating of “Neutral” to CC, setting the target price at $25 in the report published on June 07th of the previous year.
CC Trading at 48.19% from the 50-Day Moving Average
After a stumble in the market that brought CC to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 5.15% of gains for the given period.
Volatility was left at 6.15%, however, over the last 30 days, the volatility rate increased by 7.66%.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CC starting from Dignam Denise, who purchase 4,068 shares at the price of $12.06 back on Aug 08 ’25. After this action, Dignam Denise now owns 191,546 shares of Chemours Company, valued at $49,060 using the latest closing price.
Gumpel Damian, the insider of Chemours Company, purchase 13,400 shares at $9.22 during a trade that took place back on Jun 02 ’25, which means that Gumpel Damian is holding 123,879 shares at $123,548 based on the most recent closing price.
Stock Fundamentals for CC
Current profitability levels for the company are sitting at:
- 0.06% for the present operating margin
- 0.17% for the gross margin
The net margin for Chemours Company stands at -0.06%. The total capital return value is set at 0.06%. Equity return is now at value -69.74%, with -4.43% for asset returns.
Based on Chemours Company (CC), the company’s capital structure generated 0.94 points at debt to capital in total, while cash flow to debt ratio is standing at 0.06. The debt to equity ratio resting at 14.82. The interest coverage ratio of the stock is 1.23.
Currently, EBITDA for the company is $692.0 million with net debt to EBITDA at 5.78. When we switch over and look at the enterprise to sales, we see a ratio of 1.18. The receivables turnover for the company is 6.2for trailing twelve months and the total asset turnover is 0.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.71.
Conclusion
In conclusion, Chemours Company (CC) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.